Ken Griffin Penumbra Inc Put Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$172.27 - $223.95 $3.55 Million - $4.61 Million	-20,600 Reduced 40.23%	30,600 $5.51 Million
Q1 2024 May 15, 2024	SELL	$220.09 - $273.15 $10.4 Million - $12.9 Million	-47,400 Reduced 48.07%	51,200 $11.4 Million
Q4 2023 Feb 14, 2024	BUY	$181.44 - $260.22 $4.45 Million - $6.38 Million	24,500 Added 33.06%	98,600 $24.8 Million
Q3 2023 Nov 14, 2023	BUY	$240.69 - $338.77 $11.7 Million - $16.5 Million	48,800 Added 192.89%	74,100 $17.9 Million
Q2 2023 Aug 14, 2023	SELL	$271.54 - $344.06 $3.69 Million - $4.68 Million	-13,600 Reduced 34.96%	25,300 $8.7 Million
Q1 2023 May 15, 2023	BUY	$220.43 - $278.69 $3.55 Million - $4.49 Million	16,100 Added 70.61%	38,900 $10.8 Million
Q4 2022 Feb 14, 2023	BUY	$151.88 - $228.5 $167,068 - $251,350	1,100 Added 5.07%	22,800 $5.07 Million
Q3 2022 Nov 14, 2022	SELL	$120.36 - $205.88 $2.02 Million - $3.46 Million	-16,800 Reduced 43.64%	21,700 $4.11 Million

383

29.6M

285K

168K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $7.61B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.